ERICA BUSTILLO: Open Payments
NPI 1033794052 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 47 payments from 17 companies in 2025. Trend: 2023 $505 · 2024 $1,201 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $205 |
| PFIZER INC. | 5 | $91 |
| Merck Sharp & Dohme LLC | 5 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $77 |
| Alnylam Pharmaceuticals Inc. | 2 | $75 |
| Boston Scientific Corporation | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| Amgen Inc. | 3 | $56 |
| AtriCure, Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
Products named: LEQVIO, VYNDAQEL, VERQUVO, WAINUA, ONPATTRO, REPATHA, SYNERGY ABLATION SYSTEM, WATCHMAN FLX.
Industry payments across LA — which companies pay providers there.
